Market closed
Access this stock data via API
Subscribe
Tekmira Pharmaceuticals Corporation
0
0
0%

Financials

Income statement

Fiscal date Aug 2024 May 2024 Feb 2024 Nov 2023
Total reported revenue 2.8B 2.8B 2.6B 2.0B
Cost of revenue 1.8B 1.8B 1.8B 1.4B
Gross profit 998.4M 946.5M 802.2M 622.5M
Operating expense
Research & development
Selling general and admin
Other operating expenses
Operating income 54.1M -42.3M 48.3M -136.6M
Non operating interest income
Income
Expense 5.2M 5.0M 3.9M 2.5M
Other income expense
Pretax income -2.8M -10.2M 89.9M -66.6M
Tax provision 34.5M 18.4M -6.2M -11.2M
Net income -37.3M -28.7M 96.1M -55.4M
Basic EPS -2.6
Diluted EPS -2.6
Basic average shares 11.8M
Diluted average shares 11.8M
EBITDA 70.8M 4.7M 105.7M -60.0M
Net income from continuing op.
Minority interests 1.1M -1.9M -1.2M -24K
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 6 hours 15 minutes

02:44
00:00
09:00
15:30
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 15:30
All times are displayed in the Asia/Tokyo timezone (JST, UTC+09:00).